Liquid biopsy in pancreatic cancer – Current perspective and future outlook
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2023-05 · 1878 (3) · 188868
DOI: 10.1016/j.bbcan.2023.188868 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2023-05. Verfasst von Yaru Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 103 Literaturangaben.
Abstract (Originalsprache)
Pancreatic cancer is a lethal condition with a rising incidence and often presents at an advanced stage, contributing to abysmal five-year survival rates. Unspecific symptoms and the current lack of biomarkers and screening tools hamper early diagnosis. New technologies for liquid biopsies and their respective evaluation in pancreatic cancer patients have emerged over recent years. The term liquid biopsy summarizes the sampling and analysis of circulating tumor cells (CTCs), small extracellular vesicles (sEVs), and tumor DNA (ctDNA) from body fluids. The major advantages of liquid biopsies rely on their minimal invasiveness and repeatability, allowing serial sampling for dynamic insights to aid diagnosis, particularly early detection, risk stratification, and precision medicine in pancreatic cancer. However, liquid biopsies have not yet developed into a new pillar for clinicians' routine armamentarium. Here, we summarize recent findings on the use of liquid biopsy in pancreatic cancer patients. We discuss current challenges and future perspectives of this potentially powerful alternative to conventional tissue biopsies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Biomedical Imaging and Radiological Science, China Medical University, Taichung, Taiwan; Research and Development Center for Immunology, China Medical University, Taichung, Taiwan.
- Precision Immunotherapy, Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
- Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Key Laboratory of Oncogenes and Related Genes, Shanghai Jiao Tong University School of Medicine,…
Zitieren
APA
Zhao, Y., Tang, J., Jiang, K., Liu, S. Y., Aicher, A., & Heeschen, C. (2023). Liquid biopsy in pancreatic cancer – Current perspective and future outlook. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1878(3), 188868. https://doi.org/10.1016/j.bbcan.2023.188868
Vancouver
Zhao Y, Tang J, Jiang K, Liu SY, Aicher A, Heeschen C. Liquid biopsy in pancreatic cancer – Current perspective and future outlook. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2023;1878(3):188868. doi:10.1016/j.bbcan.2023.188868
BibTeX
@article{Zhao2023,
author = {Zhao, Yaru and Tang, Jiajia and Jiang, Ke and Liu, Shin-Yi and Aicher, Alexandra and Heeschen, Christopher},
title = {Liquid biopsy in pancreatic cancer – Current perspective and future outlook},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2023},
volume = {1878},
number = {3},
pages = {188868},
doi = {10.1016/j.bbcan.2023.188868}
}
EUVIMED